Neoral

DRUG7 trials

Conditions

Chronic Hepatitis CEnd Stage Renal DiseaseEnd Stage Renal FailureImmunosuppressionKidney TransplantationOrgan TransplantationRenal Interstitial FibrosisRenal Transplant Rejection

Phase 1

Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

CompletedNCT00286871

Duke UniversityChronic Hepatitis C, Immunosuppression, Organ Transplantation

Start: 2006-02-28End: 2009-02-28Target: 40Updated: 2014-09-22

Phase 2

Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients

CompletedNCT00504543

Novartis PharmaceuticalsKidney Transplantation

Start: 2007-07-31End: 2011-04-30Updated: 2016-11-18

Phase 3

A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

CompletedNCT00048152

Hoffmann-La RocheKidney Transplantation

Start: 2000-12-31End: 2006-03-31Updated: 2016-11-02

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

CompletedNCT01079143

Novartis PharmaceuticalsRenal Interstitial Fibrosis

Start: 2009-09-30End: 2012-06-30Updated: 2014-03-18

Phase 4

Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation

CompletedNCT00656695

Imam Khomeini HospitalEnd Stage Renal Disease, Renal Transplantation

Start: 2008-04-30End: 2009-10-31Updated: 2012-06-22

A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

TerminatedNCT00983645

Loma Linda UniversityRenal Transplant Rejection

Start: 2004-10-31End: 2013-03-31Updated: 2016-06-03

Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

CompletedNCT01990118

Penang Hospital, MalaysiaEnd Stage Renal Failure

Start: 2004-11-30End: 2006-05-31Updated: 2013-11-21

Related Papers

Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study

BMJ Open2021-10-0140 citations

Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study

BMJ2019-09-17310 citations